Qualifying notice for Tepadina (French, HTML)
Qualifying notice for Tepadina: French HTML file. From Health Canada, updated Nov 2023. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2023-11-01
This Notice of Compliance with Conditions-Qualifying Notice (NOC/c-QN) is to advise you that information submitted in support of the New Drug Submission for Tepadina (thiotepa), control number 168816, for the indication in combination with other chemotherapeutic products as part of a high-dose chemotherapy (HDCT) consolidation regimen followed by autologous stem cell transplantation (ASCT) for adult patients with central nervous system (CNS) lymphoma, qualifies to be considered for authorization under the Notice of Compliance with Conditions (NOC/c) Policy.
Data overview
- Formats
- HTML
- File languages
- French
- Available actions
- Access original file